The program, which is a partnership between Berkeley Public Health, UC Berkeley–based business accelerator program SkyDeck, and the Ministry of Science and Technology and the National Development Council of Taiwan, will connect the teams with health systems leaders, pharmaceutical executives, experts in regulatory and reimbursement strategies, and life science investors.